Human Metabolome Technologies, Inc. 6090.T Stock
Human Metabolome Technologies, Inc. Price Chart
Human Metabolome Technologies, Inc. 6090.T Financial and Trading Overview
| Human Metabolome Technologies, Inc. stock price | 690 JPY |
| Previous Close | 755 JPY |
| Open | 745 JPY |
| Bid | 746 JPY x 0 |
| Ask | 750 JPY x 0 |
| Day's Range | 740 - 755 JPY |
| 52 Week Range | 606 - 969 JPY |
| Volume | 12.2K JPY |
| Avg. Volume | 6.96K JPY |
| Market Cap | 4.41B JPY |
| Beta (5Y Monthly) | 0.847582 |
| PE Ratio (TTM) | 16.950306 |
| EPS (TTM) | 47.88 JPY |
| Forward Dividend & Yield | 20 (2.72%) |
| Ex-Dividend Date | June 29, 2023 |
| 1y Target Est | N/A |
6090.T Valuation Measures
| Enterprise Value | 3.04B JPY |
| Trailing P/E | 16.950306 |
| Forward P/E | 22.035397 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.4259112 |
| Price/Book (mrq) | 2.577444 |
| Enterprise Value/Revenue | 2.359 |
| Enterprise Value/EBITDA | 11.883 |
Trading Information
Human Metabolome Technologies, Inc. Stock Price History
| Beta (5Y Monthly) | 0.847582 |
| 52-Week Change | 19.27% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 969 JPY |
| 52 Week Low | 606 JPY |
| 50-Day Moving Average | 714.28 JPY |
| 200-Day Moving Average | 741.69 JPY |
6090.T Share Statistics
| Avg. Volume (3 month) | 6.96K JPY |
| Avg. Daily Volume (10-Days) | 11.08K JPY |
| Shares Outstanding | 5.91M |
| Float | 4.73M |
| Short Ratio | N/A |
| % Held by Insiders | 21.33% |
| % Held by Institutions | 9.68% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 16.61% |
| Operating Margin (ttm) | 14.36% |
| Gross Margin | 65.60% |
| EBITDA Margin | 19.85% |
Management Effectiveness
| Return on Assets (ttm) | 5.43% |
| Return on Equity (ttm) | 13.24% |
Income Statement
| Revenue (ttm) | 1.29B JPY |
| Revenue Per Share (ttm) | 218.19 JPY |
| Quarterly Revenue Growth (yoy) | -2.50% |
| Gross Profit (ttm) | 839M JPY |
| EBITDA | 255.75M JPY |
| Net Income Avi to Common (ttm) | 214M JPY |
| Diluted EPS (ttm) | 44.07 |
| Quarterly Earnings Growth (yoy) | -22.60% |
Balance Sheet
| Total Cash (mrq) | 1.51B JPY |
| Total Cash Per Share (mrq) | 256.3 JPY |
| Total Debt (mrq) | 229M JPY |
| Total Debt/Equity (mrq) | 13.38 JPY |
| Current Ratio (mrq) | 3.68 |
| Book Value Per Share (mrq) | 289.822 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Human Metabolome Technologies, Inc.
| Country | Japan |
| State | N/A |
| City | Tsuruoka |
| Address | 246-2 Mizukami Kakuganji |
| ZIP | 997-0052 |
| Phone | 81 3 3551 2180 |
| Website | https://www.humanmetabolome.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 65 |
Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted assays, flux analysis, and lipidomics services. It also develops biomarkers, such as Phosphorylethanolamine, a biomarker for major depressive disorder and measured in blood plasma. The company offers solutions for cancer metabolism, metabolic flux analysis, infectious diseases, basic science, preclinical and clinical, food and nutrition, and microbiome applications. It has a collaboration with the Institute for Advanced Biosciences and Keio University for the development of metabolome analysis technology. The company was incorporated in 2003 and is headquartered in Tsuruoka, Japan.
Q&A For Human Metabolome Technologies, Inc. Stock
What is a current 6090.T stock price?
Human Metabolome Technologies, Inc. 6090.T stock price today per share is 690 JPY.
How to purchase Human Metabolome Technologies, Inc. stock?
You can buy 6090.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Human Metabolome Technologies, Inc.?
The stock symbol or ticker of Human Metabolome Technologies, Inc. is 6090.T.
Which industry does the Human Metabolome Technologies, Inc. company belong to?
The Human Metabolome Technologies, Inc. industry is Biotechnology.
How many shares does Human Metabolome Technologies, Inc. have in circulation?
The max supply of Human Metabolome Technologies, Inc. shares is 5.92M.
What is Human Metabolome Technologies, Inc. Price to Earnings Ratio (PE Ratio)?
Human Metabolome Technologies, Inc. PE Ratio is 14.41102700 now.
What was Human Metabolome Technologies, Inc. earnings per share over the trailing 12 months (TTM)?
Human Metabolome Technologies, Inc. EPS is 47.88 JPY over the trailing 12 months.
Which sector does the Human Metabolome Technologies, Inc. company belong to?
The Human Metabolome Technologies, Inc. sector is Healthcare.